Patents by Inventor Paul Uster

Paul Uster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060246126
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Application
    Filed: June 30, 2006
    Publication date: November 2, 2006
    Inventors: Theresa Allen, Paul Uster, Francis Martin, Samuel Zalipsky
  • Patent number: 7122202
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: October 17, 2006
    Assignee: Alza Corporation
    Inventors: Theresa M. Allen, Paul Uster, Francis J. Martin, Samuel Zalipsky
  • Publication number: 20050169980
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Application
    Filed: February 2, 2005
    Publication date: August 4, 2005
    Inventors: Theresa Allen, Paul Uster, Francis Martin, Samuel Zalipsky
  • Publication number: 20050136064
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Application
    Filed: February 2, 2005
    Publication date: June 23, 2005
    Inventors: Theresa Allen, Paul Uster, Francis Martin, Samuel Zalipsky
  • Publication number: 20040191250
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Application
    Filed: April 7, 2004
    Publication date: September 30, 2004
    Applicant: Alza Corporation
    Inventors: Theresa M. Allen, Paul Uster, Francis J. Martin, Samuel Zalipsky
  • Publication number: 20040191307
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Application
    Filed: April 7, 2004
    Publication date: September 30, 2004
    Applicants: Alza Corporation, Sequus Pharmaceuticals, Inc.
    Inventors: Theresa M. Allen, Paul Uster, Francis J. Martin, Samuel Zalipsky
  • Patent number: 6543443
    Abstract: A nebulizing device having two or more nebulizing elements. The nebulizing device may be used to deliver two or more fluids to the patient or may be used for enhanced fluid flow of a single fluid. The nebulizing elements are preferably vibrating elements with holes therein through which the fluid is expelled when the vibrating elements are vibrated.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: April 8, 2003
    Assignee: Aerogen, Inc.
    Inventors: Michael Klimowicz, Richard Stevens, Paul Uster, Joseph Maxwell, Markus Flierl
  • Patent number: 6316024
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Grant
    Filed: March 2, 2000
    Date of Patent: November 13, 2001
    Assignee: Sequus Pharmaceuticals, Inc.
    Inventors: Theresa M. Allen, Paul Uster, Francis J. Martin, Samuel Zalipsky
  • Publication number: 20010038851
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Application
    Filed: June 7, 2001
    Publication date: November 8, 2001
    Applicant: Alza Corporation
    Inventors: Theresa M. Allen, Paul Uster, Francis J. Martin, Samuel Zalipsky
  • Patent number: 6056973
    Abstract: Reagents for use in preparing a therapeutic liposome composition sensitized to a target cell are described. The reagents include a liposomal composition composed of pre-formed liposomes having an entrapped therapeutic agent and a plurality of targeting conjugates composed of a lipid, a hydrophilic polymer and a targeting ligand. The therapeutic, target-cell sensitized liposome composition is formed by incubating the liposomal composition with a selected conjugate.
    Type: Grant
    Filed: August 21, 1998
    Date of Patent: May 2, 2000
    Assignee: Sequus Pharmaceuticals, Inc.
    Inventors: Theresa M. Allen, Paul Uster, Francis J. Martin, Samuel Zalipsky